Liver cirrhosis patients needed for antibiotic safety study
NCT ID NCT05960006
First seen Jan 08, 2026 · Last updated May 18, 2026 · Updated 25 times
Summary
This study looked at how the antibiotic ceftriaxone moves through the blood and belly fluid in 20 patients with liver cirrhosis and ascites (fluid buildup). Researchers wanted to understand if kidney problems change drug levels, which could affect safety and dosing. The goal is to help doctors give the right amount of antibiotic to avoid toxicity while still fighting infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam university medical centers location AMC
Amsterdam, 1105AZ, Netherlands
Conditions
Explore the condition pages connected to this study.